BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang D, Zhao D, Li J, Wu Y, Du L, Xia XH, Li X, Deng Y, Li Z, Huang Y. Continuous Vector-free Gene Transfer with a Novel Microfluidic Chip and Nanoneedle Array. Curr Drug Deliv 2019;16:164-70. [PMID: 30332957 DOI: 10.2174/1567201815666181017095044] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang M, Weng Y, Cao Z, Guo S, Hu B, Lu M, Guo W, Yang T, Li C, Yang X, Huang Y. ROS-Activatable siRNA-Engineered Polyplex for NIR-Triggered Synergistic Cancer Treatment. ACS Appl Mater Interfaces 2020;12:32289-300. [DOI: 10.1021/acsami.0c06614] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
2 Liu H, Huang L, Mao M, Ding J, Wu G, Fan W, Yang T, Zhang M, Huang Y, Xie H. Viral Protein‐Pseudotyped and siRNA‐Electroporated Extracellular Vesicles for Cancer Immunotherapy. Adv Funct Mater 2020;30:2006515. [DOI: 10.1002/adfm.202006515] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
3 Lu M, Zhang M, Hu B, Huang Y. siRNA Design and GalNAc-Empowered Hepatic Targeted Delivery. Methods Mol Biol 2021;2282:77-100. [PMID: 33928571 DOI: 10.1007/978-1-0716-1298-9_6] [Reference Citation Analysis]
4 Hu B, Zhong L, Weng Y, Peng L, Huang Y, Zhao Y, Liang XJ. Therapeutic siRNA: state of the art. Signal Transduct Target Ther. 2020;5:101. [PMID: 32561705 DOI: 10.1038/s41392-020-0207-x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 100] [Article Influence: 99.0] [Reference Citation Analysis]
5 Weng Y, Xiao H, Zhang J, Liang XJ, Huang Y. RNAi therapeutic and its innovative biotechnological evolution. Biotechnol Adv 2019;37:801-25. [PMID: 31034960 DOI: 10.1016/j.biotechadv.2019.04.012] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 39.0] [Reference Citation Analysis]